Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: A retrospective study in Chinese patients

Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma

17 p | 5 | 3

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer

12 p | 19 | 3

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: Pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials

16 p | 6 | 2

Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients

10 p | 10 | 1

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: A retrospective analysis

8 p | 20 | 1

Treatment strategies and prognostic factors of primary gastric diffuse large B cell lymphoma: A retrospective multicenter study of 272 cases from the China lymphoma patient registry

9 p | 10 | 1

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

13 p | 14 | 0

Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis

9 p | 12 | 0

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

16 p | 9 | 0